首页 > 最新文献

Radiobiologia, radiotherapia最新文献

英文 中文
[Hyperthermia in tumor therapy]. [肿瘤热疗]。
Pub Date : 1990-01-01
J Schorcht

The application of hyperthermia in tumor therapy is expanded to a high degree. As affecting point in biological tissue the following is discussed: Cytotoxic effect with temperatures of 43 degrees C with alterations on cell membrane and in intermediate metabolism, injury of microcirculation, where--because of a pathological vascularisation--tumor tissue is affected in a stronger way than the better adapted vessel net of normal tissue. The radiosensitizing effect between 40 and 42 degrees C is of interest for radiologist. Degree and duration of temperature and the interval between irradiation and thermal application modify the amplifying thermal factor. As adjuvant therapeutic modality the hyperthermia can decrease the hypoxic radioresistant part of cells and is an additional palliative therapeutic measure. Indications within a curative radiotherapy are elaborated at present globally.

热疗在肿瘤治疗中的应用得到了高度拓展。作为生物组织的影响点,我们讨论了以下几点:43摄氏度温度下的细胞毒性作用,细胞膜和中间代谢的改变,微循环的损伤,其中,由于病理性血管化,肿瘤组织比正常组织的血管网受到更强的影响。40至42摄氏度之间的放射致敏效应是放射科医生感兴趣的。温度的程度和持续时间以及辐照和热应用之间的间隔改变了放大热因子。作为辅助治疗方式,热疗可以减少细胞的缺氧放射抵抗部分,是一种额外的姑息性治疗措施。目前全球对治疗性放射治疗的适应症进行了阐述。
{"title":"[Hyperthermia in tumor therapy].","authors":"J Schorcht","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The application of hyperthermia in tumor therapy is expanded to a high degree. As affecting point in biological tissue the following is discussed: Cytotoxic effect with temperatures of 43 degrees C with alterations on cell membrane and in intermediate metabolism, injury of microcirculation, where--because of a pathological vascularisation--tumor tissue is affected in a stronger way than the better adapted vessel net of normal tissue. The radiosensitizing effect between 40 and 42 degrees C is of interest for radiologist. Degree and duration of temperature and the interval between irradiation and thermal application modify the amplifying thermal factor. As adjuvant therapeutic modality the hyperthermia can decrease the hypoxic radioresistant part of cells and is an additional palliative therapeutic measure. Indications within a curative radiotherapy are elaborated at present globally.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 5","pages":"383-90"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13429222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Studies of the immunostimulating properties of lipopolysaccharides and dextran sulfate based on a model of radiogenic immunodepression]. [基于放射源性免疫抑制模型的脂多糖和硫酸葡聚糖免疫刺激特性的研究]。
Pub Date : 1990-01-01
S A Prokofjev, N L Perelygin, N B Dmitrijeva, E V Markina, B S Utesev

At a model of initial immunoresponse of mice to sheep erythrocytes the immunostimulating activity of lipopolysaccharide (LPS) and dextransulphate (DS) was tested. It was shown, that suppression of the immunosystem after influence of radiation can be compensated successfully by application of lipopolysaccharide and dextransulphate. The prophylactic application of these preparation is more ineffective.

在小鼠对绵羊红细胞的初始免疫反应模型中,检测了脂多糖(LPS)和葡聚糖(DS)的免疫刺激活性。结果表明,辐射对免疫系统的影响可以通过脂多糖和葡聚糖的应用来补偿。这些制剂的预防应用效果较差。
{"title":"[Studies of the immunostimulating properties of lipopolysaccharides and dextran sulfate based on a model of radiogenic immunodepression].","authors":"S A Prokofjev,&nbsp;N L Perelygin,&nbsp;N B Dmitrijeva,&nbsp;E V Markina,&nbsp;B S Utesev","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>At a model of initial immunoresponse of mice to sheep erythrocytes the immunostimulating activity of lipopolysaccharide (LPS) and dextransulphate (DS) was tested. It was shown, that suppression of the immunosystem after influence of radiation can be compensated successfully by application of lipopolysaccharide and dextransulphate. The prophylactic application of these preparation is more ineffective.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 3","pages":"247-55"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12861947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Determination of radiation exposure from the use of 99mTc-HM-PAO]. [使用99mTc-HM-PAO的辐射暴露测定]。
Pub Date : 1990-01-01
S Ertl, M Tautz, H Deckart, A Blottner
{"title":"[Determination of radiation exposure from the use of 99mTc-HM-PAO].","authors":"S Ertl,&nbsp;M Tautz,&nbsp;H Deckart,&nbsp;A Blottner","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 2","pages":"197-201"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13505108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haematologic changes in young adult Swiss albino mice after tritiated water administration. 幼龄成年瑞士白化病小鼠经氚化水处理后的血液学变化。
Pub Date : 1990-01-01
A L Bhatia, G L Heda, N Sharma

Tritiated water (HTO) injected intraperitoneally to Swiss albino mice at the rate of 370 kBq (10 microCi)/g body weight has been found to cause certain alterations in blood parameters 1, 5, 7 and 15 days postinjectionem. Leucocyte count dropped significantly post treatment. Differential leucocyte counting showed lymphocytes to be most affected which were reduced by 38.29% on 5th day p.i. Erythrocyte count, haemoglobin and haematocrit values though showed no significant changes at early intervals, these values were significantly lower at later intervals than those of control.

以370 kBq (10 microCi)/g体重的速率腹腔注射氚化水(HTO),可引起注射后1、5、7和15天血液参数的某些改变。治疗后白细胞计数明显下降。白细胞计数差异显示,淋巴细胞受影响最大,在第5天减少了38.29%。红细胞计数、血红蛋白和红细胞压积值虽然在早期无明显变化,但在后期显著低于对照组。
{"title":"Haematologic changes in young adult Swiss albino mice after tritiated water administration.","authors":"A L Bhatia,&nbsp;G L Heda,&nbsp;N Sharma","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tritiated water (HTO) injected intraperitoneally to Swiss albino mice at the rate of 370 kBq (10 microCi)/g body weight has been found to cause certain alterations in blood parameters 1, 5, 7 and 15 days postinjectionem. Leucocyte count dropped significantly post treatment. Differential leucocyte counting showed lymphocytes to be most affected which were reduced by 38.29% on 5th day p.i. Erythrocyte count, haemoglobin and haematocrit values though showed no significant changes at early intervals, these values were significantly lower at later intervals than those of control.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 3","pages":"293-6"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13534304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality assurance in radiotherapy--a clinical view-point. 放射治疗的质量保证——一个临床观点。
Pub Date : 1990-01-01
K Merkle, A Lessel, J Hüttner

Despite the advanced treatment methods now available, the total result in 5-year survival is 40-50% of all patients with malignancies and 20% of these patients will have the chance of a 10-year survival. In the course of their disease a radiotherapy is indicated in about 2/3 of all cancer patients. Thus, radiotherapy makes quite a considerable contribution to the qualitative improvement of the treatment of patients with malignancies. Eradication of the tumor and protection of normal tissue can be only a compromise between tumor control and the production of complications. For the risk assessment of radiotherapy, the steepness of dose-response curves is of paramount importance. That means, small errors in defining and delivering dose can have catastrophic results in terms of failure to control the patient's disease and, on the other side, in terms of complications, that means in quality of life. Although the costs of therapy, in absolute values, vary from one country to the other, it can be stated in rough approximation that a failed radiotherapy will make rise the costs by a factor of 3. Proceeding on the fact that in 30-40% of patients, who received radiotherapy, the initial treatment failed to control the primary disease, the enormous additional costs involved become obvious, not to speak of the main argument--the regrowth of the patient's tumor. For the improvement of this situation quality assurance (QA) is an essential prerequisite, which should be guaranteed in all successive steps of radiotherapy. In the paper an analysis is given for all individual steps in the chain of radiotherapeutic measures.(ABSTRACT TRUNCATED AT 250 WORDS)

尽管现在有先进的治疗方法,但所有恶性肿瘤患者的5年生存率为40-50%,其中20%的患者将有机会获得10年生存率。在他们的疾病过程中,大约三分之二的癌症患者需要进行放射治疗。因此,放射治疗对恶性肿瘤患者治疗的质量改善做出了相当大的贡献。根除肿瘤和保护正常组织只能是肿瘤控制和并发症产生之间的妥协。对于放射治疗的风险评估,剂量-反应曲线的陡峭度是至关重要的。这意味着,在确定和提供剂量方面的小错误可能会导致灾难性的结果,因为无法控制病人的疾病,另一方面,就并发症而言,这意味着生活质量。虽然治疗费用的绝对值因国家而异,但可以粗略地估计,放射治疗失败将使费用增加3倍。在30-40%接受放射治疗的患者中,最初的治疗未能控制原发疾病,从这一事实出发,所涉及的巨大额外费用变得显而易见,更不用说主要论点了——患者肿瘤的再生。为了改善这种情况,质量保证(QA)是必不可少的先决条件,在放疗的所有后续步骤中都应保证质量保证。本文对放射治疗措施链中的所有单独步骤进行了分析。(摘要删节250字)
{"title":"Quality assurance in radiotherapy--a clinical view-point.","authors":"K Merkle,&nbsp;A Lessel,&nbsp;J Hüttner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite the advanced treatment methods now available, the total result in 5-year survival is 40-50% of all patients with malignancies and 20% of these patients will have the chance of a 10-year survival. In the course of their disease a radiotherapy is indicated in about 2/3 of all cancer patients. Thus, radiotherapy makes quite a considerable contribution to the qualitative improvement of the treatment of patients with malignancies. Eradication of the tumor and protection of normal tissue can be only a compromise between tumor control and the production of complications. For the risk assessment of radiotherapy, the steepness of dose-response curves is of paramount importance. That means, small errors in defining and delivering dose can have catastrophic results in terms of failure to control the patient's disease and, on the other side, in terms of complications, that means in quality of life. Although the costs of therapy, in absolute values, vary from one country to the other, it can be stated in rough approximation that a failed radiotherapy will make rise the costs by a factor of 3. Proceeding on the fact that in 30-40% of patients, who received radiotherapy, the initial treatment failed to control the primary disease, the enormous additional costs involved become obvious, not to speak of the main argument--the regrowth of the patient's tumor. For the improvement of this situation quality assurance (QA) is an essential prerequisite, which should be guaranteed in all successive steps of radiotherapy. In the paper an analysis is given for all individual steps in the chain of radiotherapeutic measures.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 1","pages":"19-23"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13491794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Radiotherapy in the treatment concept of pituitary adenomas]. [放疗在垂体腺瘤治疗理念中的应用]。
Pub Date : 1990-01-01
P Feyer, U Linke, D Pittasch, F Kamprad
{"title":"[Radiotherapy in the treatment concept of pituitary adenomas].","authors":"P Feyer,&nbsp;U Linke,&nbsp;D Pittasch,&nbsp;F Kamprad","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 1","pages":"33-7"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13491795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[3-D-irradiation planning based on the TOMOSCAN CX (Philips) computed tomograph. I. Principles of the CT-irradiation planning program. II. CT-irradiation planning for after-irradiation of breast cancer]. [基于TOMOSCAN CX (Philips)计算机层析成像的三维辐照计划。]1 . ct辐照计划程序的原则。2乳腺癌放疗后ct照射规划[j]。
Pub Date : 1990-01-01
E Tabbert, R Bollmann

Actually CT-cross-sections are the best base for irradiation planning. Bases are represented to use CT-picture matrices of scanner TOMOSCAN CX (Philips) for irradiation planning. The direct application of CT-pictures is done in "off-line"-running with the magnetic tape set. For figuring on colour display and estimation of density matrix limits of Hounsfield values are given. Adjustment of the CT to take off scan planes requires a special work-regime for irradiation planning. Repair and use of defective CT-pictures are realized by input of specific outlines. In daily routine the output of sagittal dose distribution is most advantageous in form of a table. Application of this CT-irradiation planning system, being implemented on microcalculator K 1630, is shown for telecobalt irradiation of mammary carcinoma.

实际上,ct横截面是制定辐照计划的最佳依据。基地表示使用扫描仪TOMOSCAN CX(飞利浦)的ct图像矩阵进行辐照计划。ct图像的直接应用是在磁带设置的“离线”运行中完成的。为了实现彩色显示和密度矩阵的估计,给出了霍斯菲尔德值的极限。调整CT以起飞扫描平面需要一个特殊的辐照计划工作制度。缺陷ct图像的修复和使用是通过输入特定的轮廓来实现的。在日常工作中,矢状面剂量分布以表格形式输出是最有利的。图示在微型计算机k1630上实现的ct辐照计划系统在乳腺癌远程钴辐照中的应用。
{"title":"[3-D-irradiation planning based on the TOMOSCAN CX (Philips) computed tomograph. I. Principles of the CT-irradiation planning program. II. CT-irradiation planning for after-irradiation of breast cancer].","authors":"E Tabbert,&nbsp;R Bollmann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Actually CT-cross-sections are the best base for irradiation planning. Bases are represented to use CT-picture matrices of scanner TOMOSCAN CX (Philips) for irradiation planning. The direct application of CT-pictures is done in \"off-line\"-running with the magnetic tape set. For figuring on colour display and estimation of density matrix limits of Hounsfield values are given. Adjustment of the CT to take off scan planes requires a special work-regime for irradiation planning. Repair and use of defective CT-pictures are realized by input of specific outlines. In daily routine the output of sagittal dose distribution is most advantageous in form of a table. Application of this CT-irradiation planning system, being implemented on microcalculator K 1630, is shown for telecobalt irradiation of mammary carcinoma.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 2","pages":"101-17"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13506730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A retrospective study of the results of postoperative radiotherapy of hypernephroma]. 【高肾瘤术后放疗结果的回顾性研究】。
Pub Date : 1990-01-01
M Eilenberger, R Kodym, R Seyss

Retrospectively the patients were analyzed, postoperatively irradiated because of a hypernephroidal kidney carcinoma during the years 1978 to 1988. With a total number of 44 patients 12 were in stage I (Robson), 13 in stage II, 17 in stage III and 2 in stage IV. The probabilities for a tumor-free survival of five years were 81%, 59% and 30% for the stages I to III. The local recurrence rate was 7%, caused by exclusion of clinically negative lymph-nodes from irradiation field. In addition to survival probabilities the complication rate of radiotherapy is analyzed too. To this additionally to analysis of symptoms of a possible side-effect the nuclear medical investigation of function of the remaining kidney was done in 9 selected tumor-free patients being irradiated in different techniques. A normal function was found in all cases. No severe side-effects can be shown in irradiated patients. Consequently the postoperative radiotherapy in hypernephroma is a supportive therapy of advanced tumor stages without severe side-effects. Further and greater planned analyses are necessary to comprehend prognostic factors.

回顾性分析了1978 ~ 1988年间因高肾样肾癌术后放疗的病例。共有44例患者,12例为I期(Robson), 13例为II期,17例为III期,2例为IV期。I至III期无肿瘤生存率分别为81%,59%和30%。局部复发率为7%,这是由于临床阴性淋巴结被排除在照射场之外所致。除生存概率外,还分析了放疗的并发症发生率。为此,除了分析可能的副作用的症状外,还对9名选择的以不同技术照射的无肿瘤患者进行了剩余肾脏功能的核医学调查。所有病例均显示功能正常。在接受过放射治疗的患者中没有出现严重的副作用。因此,术后放射治疗是晚期肿瘤的一种支持治疗,没有严重的副作用。进一步和更大的有计划的分析是必要的,以了解预后因素。
{"title":"[A retrospective study of the results of postoperative radiotherapy of hypernephroma].","authors":"M Eilenberger,&nbsp;R Kodym,&nbsp;R Seyss","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Retrospectively the patients were analyzed, postoperatively irradiated because of a hypernephroidal kidney carcinoma during the years 1978 to 1988. With a total number of 44 patients 12 were in stage I (Robson), 13 in stage II, 17 in stage III and 2 in stage IV. The probabilities for a tumor-free survival of five years were 81%, 59% and 30% for the stages I to III. The local recurrence rate was 7%, caused by exclusion of clinically negative lymph-nodes from irradiation field. In addition to survival probabilities the complication rate of radiotherapy is analyzed too. To this additionally to analysis of symptoms of a possible side-effect the nuclear medical investigation of function of the remaining kidney was done in 9 selected tumor-free patients being irradiated in different techniques. A normal function was found in all cases. No severe side-effects can be shown in irradiated patients. Consequently the postoperative radiotherapy in hypernephroma is a supportive therapy of advanced tumor stages without severe side-effects. Further and greater planned analyses are necessary to comprehend prognostic factors.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 6","pages":"491-6"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13256337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The results of radiotherapy of epicondylitis humeri using different dosages]. [不同剂量肱骨上髁炎放射治疗的结果]。
Pub Date : 1990-01-01
R Kammerer, G Bollmann, P Schwenger, G Michael, D Köppen

In a prospective analysis the effectiveness of roentgen irradiation with minimal doses (daily single doses .03 Gy up to a total dose of 1.5 Gy) was investigated in 207 patients with an epicondylitis humeri. Compared with a group of 92 patients, who were irradiated with higher doses being in general use (weekly 2x single doses 1.0 Gy to a total dose of 4.0 Gy), the therapeutic results show no significant differences. After termination of the first irradiation series an improvement of complaints was seen in half of the patients (48.8% or 50.0%). A further increase of the quota in success to 74.9% or 70.6% was found 6 weeks after termination of irradiation. By reason of radiotherapeutic results, mainly attained in chronic states of epicondylitis humeri after primary conservative therapy without success for months and partly surgical pretreatment, the radiotherapy should be used more frequently than till now, especially in consideration of its slight side-effects and injuries of patients.

在一项前瞻性分析中,对207例肱骨上髁炎患者进行了最小剂量(每日单次剂量0.03 Gy至总剂量1.5 Gy)的伦琴照射的有效性进行了研究。与一般使用较高剂量照射的92例患者(每周2次单次剂量1.0 Gy至总剂量4.0 Gy)相比,治疗结果没有显着差异。在第一次放射治疗结束后,有一半的患者(48.8%或50.0%)的抱怨有所改善。在终止辐照后6周,成功率进一步上升至74.9%或70.6%。由于放射治疗的效果,主要是在肱骨上髁炎的慢性状态下,经过几个月的初步保守治疗无效和部分手术预处理后,放射治疗应该比现在更频繁地使用,特别是考虑到它的副作用小,对患者的伤害小。
{"title":"[The results of radiotherapy of epicondylitis humeri using different dosages].","authors":"R Kammerer,&nbsp;G Bollmann,&nbsp;P Schwenger,&nbsp;G Michael,&nbsp;D Köppen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a prospective analysis the effectiveness of roentgen irradiation with minimal doses (daily single doses .03 Gy up to a total dose of 1.5 Gy) was investigated in 207 patients with an epicondylitis humeri. Compared with a group of 92 patients, who were irradiated with higher doses being in general use (weekly 2x single doses 1.0 Gy to a total dose of 4.0 Gy), the therapeutic results show no significant differences. After termination of the first irradiation series an improvement of complaints was seen in half of the patients (48.8% or 50.0%). A further increase of the quota in success to 74.9% or 70.6% was found 6 weeks after termination of irradiation. By reason of radiotherapeutic results, mainly attained in chronic states of epicondylitis humeri after primary conservative therapy without success for months and partly surgical pretreatment, the radiotherapy should be used more frequently than till now, especially in consideration of its slight side-effects and injuries of patients.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 6","pages":"503-7"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13256338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Changes in the concentration of N-acetylneuraminic acid in the blood of patients with bladder cancer during radiotherapy]. [膀胱癌放疗期间患者血液n -乙酰神经氨酸浓度的变化]。
Pub Date : 1990-01-01
S Bellmann, G Bollmann, R Kammerer, K Röder

The N-acetylneuraminic acid (N-ANA) concentration of serum in 24 patients with bladder carcinoma was measured with a modified Arzneibuch (D.L.) GDR-method before, during and after the postoperative radiotherapy. It was found that the N-ANA-concentrations in the patients operated resulted in a dependence from tumor staging already before the radiotherapy. The N-ANA concentration rose with increased staging. A temporary enhancement of the N-ANA-concentration with the maximum between 20. and 25 radiation fractions occurred in patients of staging T3 and relapses as well as with tumor cells being only little differentiated. The results are discussed in relation to the clinical importance.

用改良Arzneibuch (D.L.)法测定24例膀胱癌患者血清n -乙酰神经氨酸(N-ANA)浓度。放疗前、中、术后gdr法。我们发现手术患者体内的n - ana浓度与放疗前肿瘤分期有一定的相关性。N-ANA浓度随分期增加而升高。n - ana浓度暂时升高,最大值在20。在T3分期和复发患者中出现25个放射分数,肿瘤细胞分化很少。并就其临床意义进行了讨论。
{"title":"[Changes in the concentration of N-acetylneuraminic acid in the blood of patients with bladder cancer during radiotherapy].","authors":"S Bellmann,&nbsp;G Bollmann,&nbsp;R Kammerer,&nbsp;K Röder","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The N-acetylneuraminic acid (N-ANA) concentration of serum in 24 patients with bladder carcinoma was measured with a modified Arzneibuch (D.L.) GDR-method before, during and after the postoperative radiotherapy. It was found that the N-ANA-concentrations in the patients operated resulted in a dependence from tumor staging already before the radiotherapy. The N-ANA concentration rose with increased staging. A temporary enhancement of the N-ANA-concentration with the maximum between 20. and 25 radiation fractions occurred in patients of staging T3 and relapses as well as with tumor cells being only little differentiated. The results are discussed in relation to the clinical importance.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 6","pages":"509-15"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13256339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiobiologia, radiotherapia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1